HK1150562A1 - Composition comprising sesamin component and quercetin glycoside - Google Patents

Composition comprising sesamin component and quercetin glycoside

Info

Publication number
HK1150562A1
HK1150562A1 HK11104587.8A HK11104587A HK1150562A1 HK 1150562 A1 HK1150562 A1 HK 1150562A1 HK 11104587 A HK11104587 A HK 11104587A HK 1150562 A1 HK1150562 A1 HK 1150562A1
Authority
HK
Hong Kong
Prior art keywords
composition
quercetin glycoside
sesamin
component
sesamin component
Prior art date
Application number
HK11104587.8A
Other languages
English (en)
Inventor
Namino Tomimori
Yoshiko Ono
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of HK1150562A1 publication Critical patent/HK1150562A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • C07H17/07Benzo[b]pyran-4-ones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK11104587.8A 2007-12-28 2011-05-09 Composition comprising sesamin component and quercetin glycoside HK1150562A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007338853A JP5276316B2 (ja) 2007-12-28 2007-12-28 セサミン類及びケルセチン配糖体を含有する組成物
PCT/JP2008/073206 WO2009084482A1 (ja) 2007-12-28 2008-12-19 セサミン類及びケルセチン配糖体を含有する組成物

Publications (1)

Publication Number Publication Date
HK1150562A1 true HK1150562A1 (en) 2012-01-06

Family

ID=40824199

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11104587.8A HK1150562A1 (en) 2007-12-28 2011-05-09 Composition comprising sesamin component and quercetin glycoside

Country Status (12)

Country Link
US (1) US8653040B2 (xx)
JP (1) JP5276316B2 (xx)
KR (1) KR101514860B1 (xx)
CN (1) CN101909619B (xx)
AU (1) AU2008344481B2 (xx)
CA (1) CA2710379C (xx)
HK (1) HK1150562A1 (xx)
MY (1) MY153899A (xx)
NZ (1) NZ586196A (xx)
SG (1) SG187399A1 (xx)
TW (1) TWI429430B (xx)
WO (1) WO2009084482A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2771747A1 (en) * 2009-08-24 2011-03-10 The Board Of Governors For Higher Education, State Of Rhode Island And P Rovidence Plantations Hot-melt extruded compositions containing plant-derived phenolic materials and processes for the preparation thereof
JP2015030690A (ja) * 2013-08-01 2015-02-16 東洋精糖株式会社 プテリジン誘導体の生体吸収性が向上した組成物および生体吸収促進剤
CN103977015B (zh) * 2014-05-05 2016-10-05 南京瑞菁医药科技有限责任公司 中药毛菊苣降脂活性成分配伍组合物
CN107405329B (zh) * 2015-03-23 2021-04-09 三得利控股株式会社 昼夜节律改善用组合物
JP2019014697A (ja) * 2017-07-11 2019-01-31 株式会社アンチエイジング・プロ ポリフェノール吸収促進用組成物、ポリフェノール体内吸収性向上方法、及び経口摂取用組成物
CN109705178B (zh) * 2018-12-28 2022-12-27 贵州中医药大学 一种从小花清风藤中提取的化合物及其提取工艺和应用
WO2021006822A1 (en) * 2019-07-08 2021-01-14 Chiangmai University Pharmaceutical compositions having synergistic effects of natural extracts for cancer treatment undergoing chemotherapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0558902A (ja) * 1991-08-30 1993-03-09 Nippon Oil & Fats Co Ltd アレルギー予防油脂組成物
JPH10273444A (ja) * 1997-03-28 1998-10-13 Tama Seikagaku Kk イチョウエキスの製造方法
JP4205188B2 (ja) * 1997-10-01 2009-01-07 一丸ファルコス株式会社 メイラード反応阻害剤
JPWO2006014028A1 (ja) * 2004-08-06 2008-05-01 持田製薬株式会社 サツマイモ茎葉抽出物およびその用途
TW200633696A (en) * 2004-12-28 2006-10-01 Suntory Ltd Sesamin/episesamin compositions
JP2007137775A (ja) * 2005-11-15 2007-06-07 Kaneka Corp 破骨細胞分化抑制因子(opg)産生促進用組成物
JP4579885B2 (ja) * 2006-09-08 2010-11-10 株式会社ヤマウラ 玉葱残屑を原料とするケルセチン含有粉末とその製造方法
JP5697834B2 (ja) 2006-12-20 2015-04-08 グリコ乳業株式会社 ケルセチン生体吸収促進剤
JP2008201763A (ja) * 2007-02-22 2008-09-04 Bull-Dog Sauce Co Ltd 抗酸化組成物

Also Published As

Publication number Publication date
AU2008344481A1 (en) 2009-07-09
JP2009155312A (ja) 2009-07-16
KR20100103849A (ko) 2010-09-28
AU2008344481B2 (en) 2013-05-16
US8653040B2 (en) 2014-02-18
CA2710379A1 (en) 2009-07-09
CN101909619A (zh) 2010-12-08
CN101909619B (zh) 2012-08-29
TW200942234A (en) 2009-10-16
SG187399A1 (en) 2013-02-28
JP5276316B2 (ja) 2013-08-28
KR101514860B1 (ko) 2015-04-23
CA2710379C (en) 2016-04-19
NZ586196A (en) 2012-07-27
TWI429430B (zh) 2014-03-11
US20100311676A1 (en) 2010-12-09
WO2009084482A1 (ja) 2009-07-09
MY153899A (en) 2015-04-15

Similar Documents

Publication Publication Date Title
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
IL230759A0 (en) Converted acyl anilide, the pharmaceutical composition containing it and its uses
EP2067800A4 (en) POLYORGANOSILOXANE COMPOSITION
EP2086318A4 (en) NEUROPROTEKTIVE COMPOSITIONS AND METHOD
EP1976675A4 (en) COMPOSITION, PREPARATION OF POLYCARBOSILANES AND THEIR USES
ZA200807544B (en) Pseudoinfectious flavivirus and uses thereof
PL2207835T3 (pl) Kompozycje i wytworzone z nich wyroby
EP2056835A4 (en) PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
HK1150562A1 (en) Composition comprising sesamin component and quercetin glycoside
IL198651A0 (en) COMPOSITION COMPRISING (-)-Ôêå9-TRANS-TETRAHYDROCANNABIONOL
IL197431A0 (en) Food composition
EP2320729A4 (en) GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FROM THEREOF
EP2088865A4 (en) METHODS AND COMPOSITIONS AROUND GUGGULPHOSPHOLIPIDS
EP2189160A4 (en) COMPOSITION WITH A SESAMINE COMPONENT AND A VITAMIN B1 COMPONENT
EP1998753A4 (en) COMPOSITIONS FOR MAJOR DEPOSITION AND USES THEREOF
ZA200903304B (en) Food composition
GB0615609D0 (en) Uses and compositions comprising miRNAs
GB0715428D0 (en) Compositions and uses thereof
GB0701170D0 (en) Compositions and uses thereof
GB0622400D0 (en) Novel compositions and uses thereof
EP2010141A4 (en) HIGH DEPOSITION COMPOSITIONS AND USES THEREOF
GB0600336D0 (en) Composition and uses thereof
GB0701171D0 (en) Compositions and uses thereof
EP2090179A4 (en) FOOD COMPOSITION CONTAINING A MANO-OLIGOSACCHARIDE
GB0725264D0 (en) Compositions and uses thereof